BioCentury
ARTICLE | Company News

BioPharma Forest, KineMed deal

October 12, 2015 7:00 AM UTC

Biopharma Forest granted KineMed exclusive, worldwide rights, except Japan, Korea, Taiwan and China, to develop and commercialize synthetic ghrelin for all indications except amyotrophic lateral scle...